Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.


Latest News

Graybug Vision Expands Executive Team with Appointments of Charles P. Semba, MD, and Ward M. Peterson, PhD

June 22, 2016

– Company Also Announces Formation of its Clinical Advisory Board “Retina” – Redwood City, CA – June 21, 2016 – Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing…

More News